In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-β-cyclodextrin

References

• Bennett, J.E. (2001). Antifungal agents. In: Molinoff, P., ed. Goodman and Gilman’s The pharmacological basis of therapeutics, ed 10. New York: McGraw-Hill, 1175–90.
   Google Scholar
• Brewster, M.E., Anderson, W.R., Meinsma, D., Moreno, D., Webb, A.I., Pablo, L., Estes, K.S., Derendorf, H., Bodor, N., Sawchuk, R., Cheung, B., Pop, E. (1997). Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-β-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J Pharm Sci. 86:335–9.
   PubMed Web of Science ®Google Scholar
• Brewster, M.E., Loftsson, T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 59:645–66.
   PubMed Web of Science ®Google Scholar
• Budavari, S. (1989). The Merck index. 11th ed. Budavari, S., ed. Rahway, NJ: Merck and Co., Inc., 835.
   Google Scholar
• Carlson, J.A., Mann, H.J., Canafax, D.M. (1983). Effect of pH on disintegration and dissolution of ketoconazole tablets. Am J Hosp Pharm. 40:1334–6.
   PubMedGoogle Scholar
• Chen, H., Gao, J., Wang, F., Liang, W. (2007). Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv. 14:201–8.
   PubMed Web of Science ®Google Scholar
• Cordoba-Diaz, D., Cordoba-Diaz, M., Awad, S., Cordoba-Borrego, M. (2001). Effect of pharmacotechnical design on the in vitro interaction of ketoconazole tablets with non-systemic antacids. Int J Pharm. 226:1–8.
   PubMedGoogle Scholar
• Esclusa-Diaz, M.T., Gayo-Otero, M., Pérez-Marcos M.B., Vila-Jato, J.L., Torres-Labandeira, J.J. (1996a). Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes. Int J Pharm. 142:183–7.
   Web of Science ®Google Scholar
• Esclusa-Diaz, M.T., Guimaraens-Mendez, M., Perez-Marcos, M.B., Vila-Jato, J.L., Torres-Labandeira, J.J. (1996b). Characterization and in vitro dissolution behaviour of ketoconazole: β- and 2-hydroxypropyl-β-cyclodextrin inclusion compounds. Int J Pharm. 143:203–10.
   Google Scholar
• Evrard, B., Chiap, P., DeTullio, P., Ghalmi, F., Piel, G., Van Hees T., Crommen, J., Losson, B., Delattre, L. (2002). Oral bioavailability in sheep of albendazole from suspension and from a solution containing hydroxypropyl-β-cyclodextrin. J Contr Rel. 85:45–50.
   PubMed Web of Science ®Google Scholar
• Govindarajan, R., Nagarsenker, M.S. (2005). Formulation studies and in vivo evaluation of a flurbiprofen-hydroxypropyl β-cyclodextrin system. Pharm Dev Tech. 1:105–14.
   Google Scholar
• Hoeschele, J.D., Roy, A.K., Pecoraro, V.L., Carver, P.L. (1994). In vitro analysis of the interaction between sucralfate and ketoconazole. Antimicrob Agents Chemother. 38:319–25.
   PubMed Web of Science ®Google Scholar
• Hörter, D., Dressman, J.B. (1997). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 25:3–14.
   Web of Science ®Google Scholar
• Ishikawa, T., Watanabe, Y., Takayama, K., Endo, H., Matsumoto M. (2000). Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm. 202:173–8.
   PubMed Web of Science ®Google Scholar
• Jarvinen, T., Jarvinen, K., Schwarting, N., Stella, V.J. (1995). β-cyclodextrin derivates, SBE- β-CD and HP- β-CD, increase the oral bioavailability of cinnarizine in beagle dogs. J Pharm Sci. 84:295–9.
   PubMed Web of Science ®Google Scholar
• Karasulu, H.Y., Taneri, F., Sanal, E., Guneri, T., Ertan, G. (2002). Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery. J Microencapsul. 19:357–62.
   PubMed Web of Science ®Google Scholar
• Kovacs, K., Stampf, G., Klebovich, I., Antal, I., Ludányi, K. (2009). Aqueous solvent system for the solubilization of azole compounds. Eur J Pharm Sci. 36:352–8.
   PubMed Web of Science ®Google Scholar
• Lelawongs, P., Barone, J.A., Colaizzi, J.L., Hsuan, A.T.M., Mechlinski, W., Legendre, R., Guarnieri, J. (1988). Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin Pharm. 7:228–35.
   PubMedGoogle Scholar
• Loftsson, T., Hreinsdottir, D., Mason, M. (2005). Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 302:18–28.
   PubMed Web of Science ®Google Scholar
• Maeda, T., Takenaka, H., Yamahira, H., Noguchi, T. (1979). Use of rabbits for GI drug absorption studies: physiological study of stomach-emptying controlled rabbits. Chem Pharm Bull. 27:3066–72.
   PubMed Web of Science ®Google Scholar
• Miyake, K., Arima, H., Hirayama, F., Yamamoto, M., Horikawa, T., Sumiyoshi, H., Noda, S., Uekama, K. (2000). Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-cyclodextrin. Pharm Dev Tech. 5:399–407.
   PubMed Web of Science ®Google Scholar
• Pietra, A.M., Cavrini, V., Andrisano, V., Gatti, R. (1992). HPLC analysis of imidazole antimycotic drugs in pharmaceutical formulations. J Pharm Biomed Anal. 10:873–9.
   PubMed Web of Science ®Google Scholar
• Pitha, J., Pitha, J. (1985). Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients. J Pharm Sci. 74:987–90.
   PubMed Web of Science ®Google Scholar
• Puglisi, G., Ventura, C.A., Spadaro, A., Campana, G., Spampinato, S. (1995). Differential effects of modified β-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration. J Pharm Pharmacol. 47:120–3.
   PubMed Web of Science ®Google Scholar
• Riley, C.M. (1986). Determination of ketoconazole in the plasma, liver, lung and adrenal of the rat high-performance liquid chromatography. J Chrom Biomed Appl. 377:287–94.
   Google Scholar
• Savolainen, J., Jarvinen, K., Matilainen, L., Jarvinen, T. (1998). Improved dissolution and bioavailability of phenytoin by sulfobutylether-β-cyclodextrin ((SBE)7m-β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) complexation. Int J Pharm. 165:69–78.
   Web of Science ®Google Scholar
• Swezey, S.F., Giacomini, K.M., Abang, A., Brass, C., Stevens, D.A., Blaschke, T.F. (1982). Measurement of ketoconazole, a new antifungal agent, by high-performance liquid chromatography. J Chromatogr Biomed Appl. 227:510–5.
   Google Scholar
• Szente, L., Szejtli, J. (1999). Highly soluble cyclodextrin derivatives: chemistry, properties, and trens in development. Adv Drug Del Rev. 36:17–28.
   PubMed Web of Science ®Google Scholar
• Taneri, F., Guneri, T., Aigner, Z., Berkesi, O., Kata, M. (2003a). Thermoanalytical studies on complexes of ketoconazole with cyclodextrin derivatives. J Therm Anal Calor. 74:769–77.
   Web of Science ®Google Scholar
• Taneri, F., Guneri, T., Aigner, Z., Kata, M. (2002). Improvement in the physicochemical properties of ketoconazole through complexation with cyclodextrin derivatives. J Incl Phenom Macrocycl Chem. 44:257–60.
   Web of Science ®Google Scholar
• Taneri, F., Guneri, T., Aigner, Z., Kata, M. (2003b). Influence of cyclodextrin complexation on the physicochemical and biopharmaceutical properties of ketoconazole. J Incl Phenom Macrocycl Chem. 47:15–23.
   Web of Science ®Google Scholar
• Vatsaraj, N., Zia, H., Needham, T. (2002). Formulation and optimization of a sustained-release tablet of ketorolac tromethamine. Drug Deliv. 9:153–9.
   PubMed Web of Science ®Google Scholar
• Velikinac, I., Cudina, O., Jankovic, I., Agbaba, D., Vladimirov, S. (2004). Comparison of capillary zone electrophoresis and high performance liquid chromatography methods for quantitative determination of ketoconazole in drug formulations. Il Farmaco. 59:419–24.
   PubMedGoogle Scholar